Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-183797
Filing Date
2025-08-20
Accepted
2025-08-20 08:53:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d947368ddefa14a.htm DEFA14A 1752063
2 GRAPHIC g947368g0819233955221.jpg GRAPHIC 3969
3 GRAPHIC g947368g0819233955913.jpg GRAPHIC 5316
  Complete submission text file 0001193125-25-183797.txt   1766355
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Filer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41837 | Film No.: 251234070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)